Efficacy of a silver colloidal gel against selected oral bacteria <i>in vitro</i>

Phat L. Tran; Keaton Luth; James Wang; Coby Ray; Anselm de Souza; Dilip Mehta; K. W. Moeller; C. D. Moeller; Ted W. Reid

doi:10.12688/f1000research.17707.1

Home Browse Efficacy of a silver colloidal gel against selected oral bacteria...

ALL Metrics

-

Views

-

Downloads

Get PDF

Get XML

Export

▬

✚

Research Article

Efficacy of a silver colloidal gel against selected oral bacteria in vitro

[version 1; peer review: 2 approved, 1 approved with reservations]

Phat L. Tran¹, Keaton Luth¹, James Wang¹, [...] Coby Ray¹, Anselm de Souza², Dilip Mehta², K. W. Moeller³, C. D. Moeller³, Ted W. Reid^1,4

Phat L. Tran¹, Keaton Luth¹, [...] James Wang¹, Coby Ray¹, Anselm de Souza², Dilip Mehta², K. W. Moeller³, C. D. Moeller³, Ted W. Reid^1,4

PUBLISHED 07 Mar 2019

Author details Author details

¹ Departments of Ophthalmology and Visual Sciences, Texas Tech University Health Sciences Center, Lubbock, Texas, USA
² Viridis BioPharma Pvt Ltd, Mumbai, Maharashtra, India
³ American Biotech Labs LLC, Alpine, Utah, USA
⁴ Selenium Ltd, Austin, TX, USA

Phat L. Tran
Roles: Investigation, Writing – Review & Editing

Keaton Luth
Roles: Writing – Review & Editing

James Wang
Roles: Writing – Review & Editing

Coby Ray
Roles: Writing – Review & Editing

Anselm de Souza
Roles: Conceptualization

Dilip Mehta
Roles: Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing

K. W. Moeller
Roles: Writing – Review & Editing

C. D. Moeller
Roles: Writing – Review & Editing

Ted W. Reid
Roles: Project Administration, Writing – Original Draft Preparation, Writing – Review & Editing

OPEN PEER REVIEW

REVIEWER STATUS

Abstract

Background: It is necessary to develop new strategies to protect against bacteria such as Streptococcus mutans, Streptococcus sanguis, and Streptococcus salivarius, which contribute to tooth decay and plaque formation. Our current study investigated the efficacy of a colloidal silver gel in inhibiting biofilm formation by these principal oral bacteria, in vitro. The aim of this study was to assess the efficacy of a colloidal silver gel formulation for inhibiting bacterial biofilm formation (Ag-gel) by the principal bacteria that cause plaque formation and tooth decay.
Methods: The effect of Ag-gel on viability of S. mutans, S. sanguis, and S. salivarius was assessed by quantifying their colony forming units (CFU) in presence or absence of the test gel. The effect of this formulation on biofilm-forming ability of these bacteria was studied through scanning electron microscopy.
Results: Using the CFU assays, over 6 logs of inhibition (100%) were found for S. mutans, S. sanguis, and S. salivarius for the Ag-gel-treated bacteria when compared with the control gel. In addition, the Ag-gel also inhibited biofilm formation by these three bacteria mixed together. These results were confirmed by scanning electron microscopy.
Conclusions: The Ag-gel was effective in preventing biofilm formation by S. mutans, S. sanguis, and S. salivarius. This Ag-gel should be tested for the ability to block plaque formation in the mouth, through its use as a tooth paste.

Keywords

Silver, biofilm, dental plaque, dental caries

Corresponding author: Ted W. Reid

Competing interests: Dr. Dilip Mehta and Dr. Anselm de Souza are directors at Viridis BioPharma Pvt. Ltd. and K W Moeller and C D Moeller are directors at American Biotech Labs.

Grant information: This study was funded by Viridis BioPharma Pvt. Ltd.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Copyright: © 2019 Tran PL et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite: Tran PL, Luth K, Wang J et al. Efficacy of a silver colloidal gel against selected oral bacteria in vitro [version 1; peer review: 2 approved, 1 approved with reservations]. F1000Research 2019, 8:267 (https://doi.org/10.12688/f1000research.17707.1) First published: 07 Mar 2019, 8:267 (https://doi.org/10.12688/f1000research.17707.1) Latest published: 07 Mar 2019, 8:267 (https://doi.org/10.12688/f1000research.17707.1)

Introduction

Problems associated with maintenance of oral health are faced by many people throughout the world, irrespective of their age and gender. The most common oral problems amongst all are dental caries, bleeding gums (periodontal diseases) and oral cancers¹. Over few decades, the severity and prevalence of dental caries, and oral cancer, which can be a fatal condition, have increased^2,3.

In the US, caries were estimated to be five times as common as asthma and seven times as common as allergic rhinitis³. According to the World Health Organization (WHO), dental caries are caused due to high sugar consumption, which is also linked with being overweight and obesity⁴. The incidence of periodontal diseases is estimated to be about 20–50% of the global population⁵. There are two approaches for the management of caries: extraction and preventions. The primary treatment modality for these caries, though very painful, is extraction of carious teeth^2,3. The routine prevention measures for dental caries are to maintain oral hygiene, involving the use of fluoride toothpaste and/or xylitol^6,7. Looking at the currently prevailing painful treatment, there is a need for new products to be developed for the prevention of oral cavities. The pathological organisms responsible for these caries/ periodontal diseases are Streptococcus mutans, Streptococcus sanguis and Streptococcus salivarius.

Since mouth washes and different tinctures have been found to be ineffective against dental biofilm formation⁸, finding novel products effective against cariogenic microbes like S. mutans is important. While Listerine^®, has some antimicrobial activity, toothpastes such as Toss-K and Senquel-AD have no activity against four important dental caries pathogens⁹. Thus, the search continues for more effective agent(s)¹⁰. A novel product that is effective against biofilm formation would be an important contribution to chewing sticks, toothpastes or other dental products.

S. mutans has the ability to adhere the enamel surface, produce acid metabolites, build glycogen reserves and to synthesize extracellular polysaccharides. Mutans streptococci create acidic environment creating a risk for formation of cavity. During the formation of dental plaque, S. mutans adhere to primary colonizers by cell to cell interaction which forms biofilm on the teeth which induces bacterial growth¹¹.

Streptococcus sanguis is normally found in the human oral cavity. Due to low cariogenicity, it forms a colony on tooth surface which gets aggregated by other oral bacteria and leads to maturation of dental plaque¹². Another organism, Streptococcus salivarius belonging to the salivarius subspecies is found in oral cavity in humans a few hours after birth and remain there as the predominant inhabitant. All these organisms enhance caries formation and thus the progression of periodontal disease. The aforementioned treatment modalities are unsuccessful in controlling or killing these bacteria and hence in prevention of caries.

Silver has been used since ancient times as antibacterial agent for various pathological elements. During the last century, the antimicrobial action of silver has been investigated¹³. Colloidal silver is observed to be less toxic than ionic silver and has good compatibility with human cells. Silver was found to be effective in dentine desensitizer and is used as root canal disinfectant¹⁴. Silver nanoparticles are also used in dental material depending on the type of material being used. For example, titanium samples are mainly soaked in AgNO₃ solution for dental implants to avoid bacterial contamination¹⁵. The mechanism of action of silver compounds on carious tooth is to inhibit demineralization process and anti-bacterial effect by interfering with bacterial cell membrane, cytoplasmic enzyme and inhibition of DNA replication of bacteria¹⁴.

Oral health being a global concern, it is essential to develop strategies to prevent dental caries and plaque formation. This study aimed at investigating the efficacy of a colloidal silver gel in inhibiting biofilm formation in vitro by the principal oral bacteria, Streptococcus mutans, Streptococcus sanguis and Streptococcus salivarius.

Methods

Bacterial strains, media, and growth conditions

Streptococcus salivarius strain ATCC® 13419^TM, Streptococcus sanguis ATCC^® 10556^TM, and Streptococcus mutans strain ATCC® 35668^TM were obtained from Remel (Lenexa, KS, USA). S. salivarius, S. sanguis, and S. mutans were routinely grown in Brain Heart Infusion (BHI, #53286, Sigma-Aldrich, St. Louis, MO), at 37°C for 24 h.

Colloidal silver materials

Colloidal silver in a gel form was obtained from Viridis BioPharma Pvt., Ltd. (Mumbai, India). It was tested by evenly spreading 0.5 g on a 6-mm blank paper disc (BD Diagnostic System, Sparks, US) inoculated with the bacteria listed in the above paragraph. We assessed the bacteria remaining on the disc by the CFU assays below.

In vitro colony forming unit (CFU) assays

A total of three blank sterile (6 mm diameter) cellulose paper discs were placed onto individual LB agar plates. Approximately 1x10³ CFUs of the test bacteria were inoculated onto each disc. In the biofilm mixture study, approximately 4x10² of each bacterium were combined together. Either no gel (untreated), Ag-gel, or placebo gel (Viridis gel without Ag), were placed over the discs inoculated with bacteria. The plates were incubated under micro-aerobic conditions, which were generated by placing the plates inside a gas jar containing an EZ GasPak (Catalog no. 260678, BD, Franklin Lakes, NJ, USA) at 37°C for 24 h. Following incubation, each cellulose disc was analyzed for the remaining viable bacteria by the CFU assay as previously described¹⁶. Each piece was carefully removed from the well, rinsed gently with sterile distilled H₂O, and placed in a microcentrifuge tube containing 1 ml PBS. The tubes were placed in a water bath sonicator for 5 min to loosen the cells within the biofilm and then vigorously vortexed 3 times for 1 min to detach the cells. Suspended cells were serially diluted 10-fold in PBS, and 10-µl aliquots of each dilution were spotted onto BHI plates. The plates were incubated at 37°C for 24 h. In experiments where no bacteria were detected, the remaining 900 µl of undiluted samples were tested. Thus, the equation for back-calculating the bacterial concentration was CFU x dilution factor x 100, with the exception of the 100-µl sample which was calculated as CFU x 10. This means that the smallest number of bacteria that we could detect would be approximately 1 bacterium. All experiments were performed in triplicate.

Scanning electron microscopy (SEM)

Biofilms formed on discs were prepared for SEM by standard techniques and the experiment was performed as previously described^16–18. S. salivarius, S. sanguis, S. mutans or a mixture of S. salivarius, S. sanguis, and S. mutans biofilms were established on cellulose discs (with or without silver gel, as described above). After 24 h of incubation, each cellulose disc and any adherent bacteria were fixed with 2% (wt/vol) glutaraldehyde in filter-sterilized 0.05 M PBS (pH 7.4) at room temperature for 16 h and then rinsed three times for 15 min each in 0.05 M PBS. The fixed cellulose discs were then dehydrated in successive ethanol-water mixtures with increasing ethanol concentrations (20%, 40%, 60%, 80%, and 95% [vol/vol]) for 15 min each and then twice in absolute ethanol for 15 min. The ethanol-dehydrated samples were then placed in an absolute ethanol bath, which was placed in an EMS 850 critical point drier (Electron Microscopy Sciences, Hatfield, PA). The ethanol was replaced by successive additions of liquid carbon dioxide. Once the liquid CO₂ had replaced the ethanol, the chamber was heated under pressure to reach the critical evaporation point of carbon dioxide. The chamber was then slowly vented of gaseous CO₂ and the dry samples removed. The dried samples were affixed to aluminum mounts with double-sided carbon adhesive tape and sputter-coated with platinum and palladium to a thickness of 18 nm. Observations were performed at 5 to 7 kV with a scanning electron microscope (Hitachi S-570; Japan). Five fields of view at 5,000X-10,000X magnification were taken at randomly chosen areas from the optic surface of each sample. A biofilm-positive field was defined as being occupied by biofilm over at least half of the visible area.

Statistical analysis

The results of the CFU assays were analyzed with Prism^® version 4.03 (GraphPad Software, San Diego, US) with 95% confidence intervals (CIs) of the difference. Comparisons of the in vitro biofilms formed on the cellulose discs with either Ag-gel dressings or Ag-free ones were analyzed by a two-tailed unpaired t-test to determine significant differences. All experiments were done in triplicate. The significance limit was P<0.05.

Results

Effect of Ag-gel on bacterial biofilm formation for in vitro CFU studies

The results for the 24-h micro-aerobic in vitro studies using S. salivarius, S. sanguis, and S. mutans isolates, as well as the mixture of all three, are illustrated in Figure 1. As seen in Figure 1A–D, the cellulose discs that had no treatment, and those that were treated with the placebo gel, showed over 6 logs of bacterial growth in each case. However, the silver containing gel showed 100% inhibition (over 6 log of killing) in all cases with S. salivarius, S. sanguis, S. mutans, or the combination of all three strains, when compared with the control, as showed in Figure 1A–D. Raw data are available on OSF¹⁹.

Figure 1. Colony forming unit analysis of biofilm formation.

(A) S. salivarius, (B) S. sanguis, (C) S. mutans or (D) all three on untreated discs, discs treated with placebo gel or discs treated with colloidal silver gel.

Effect of Ag-gel dressing on bacterial biofilm formation for in vitro SEM studies

To confirm results of CFU assay described in previous section, the biofilm formation of S. salivarius, S. sanguis, S. mutans or the mixture of all three strains was studied on cellulose discs by SEM. S. salivarius, S. sanguis, S. mutans and the mixture of all three strains, were inoculated onto the discs in the same manner as for the CFU biofilm assay. Untreated discs were coated with placebo gel only. As above the discs were incubated for 24 h under micro-aerobic conditions at 37°C. As seen in Figure 2, S. salivarius, S. sanguis, S. mutans and the mixture of all three strains, formed typical biofilms characterized by the presence of micro-colonies on the cellulose discs receiving no treatment, or treated with the placebo gel. However, no bacteria were seen on the cellulose discs treated with colloidal silver gel. These results confirm those obtained with the CFU assay. Raw SEM images are available on OSF¹⁹.

Figure 2. Scanning electron microscopy (SEM) imaging.

(A) SEM analysis of S. salivarius, S. sanguis or S. mutans biofilm formation on untreated discs, discs treated with placebo gel or discs treated with colloidal silver gel. (B) SEM of a blank disc.

Discussion

There are over 700 different species that contribute to the formation of dental biofilm (plaque)^9–11. Among these species, Streptococcus mutans, Streptococcus salavarius, and Streptococcus sanguinis are the main members of this plaque^20–22. These bacteria are also considered to be the primary etiologic agents of human dental caries^23–26. It is the interaction of S. mutans with other streptococci that is thought to be important in dental plaque formation.²⁷. S. mutans can cause cariogenicigty by the production of glucosyltransferase enzymes that allows glucose from sucrose to be used for the synthesis of glucan, and have also been implicated in heart problems^28,29. S. sanguinis is an another common organism in dental plaque, which can colonize dental cavities. An additional problem is that this organism is also often found in the bloodstream. This allows it to attach to heart valves, causing bacterial endocarditis²². Thus, S. sanguinis is a key agent in infective endocarditis²¹.

Since S. salivarius is also part of the normal human flora, it can contaminate sterile body fluid. Thus, therapeutic interventions that disrupt the cells protecting the blood vessels can allow it to enter the blood stream and cause problems in areas such as the meninges and the cerebrospinal fluid.^30–33. This results in a variety of infections such as meningitis and bacteraemia along with many other bacterial problems.^{27,30,34–39}. Thus, these three bacterial species can not only work together to form plaque on teeth, but can play a major role in other medical problems in the body.

The objective of the current study was to evaluate the test Ag-gel for its efficacy to either control or annihilate the growth of these 3 organisms. The results present quantitative data of the antimicrobial effect on S. salivarius, S. sanguis, or S. mutans bacteria, of Ag-gel, layered on a cellulose disc which was inoculated with these bacteria or a combination of all three bacterial strains. The CFU assay results of in vitro studies using Ag-gel treated dressings showed over 6 log of killing (100%) for S. salivarius, S. sanguis, or S. mutans as compared with a control gel dressing containing no Ag-gel. Since biofilms adhere strongly to surfaces, the experiments were also studied by SEM. These SEM studies confirmed the CFU results with S. salivarius, S. sanguis, or S. mutans biofilms, in the presence of Ag-gel or placebo gel. As seen in Figure 2, mature biofilms formed in the presence of the placebo gel, but none in the presence of the Ag-gel.

The mixture of these three bacteria was also studied, since it is proposed that the combination of bacteria is more resistant to growth inhibition than the individual bacteria. Similar results to the individual bacteria, (>6-log kill rate, 100%) were obtained with the combination of the three bacteria by both the CFU assay and by SEM studies.

Conclusion

An Ag-gel was found to be capable of over 6 log (100%) inhibition of S. salivarius, S. sanguis, or S. mutans bacteria, or a mixture of all three bacteria forming biofilms on cellulose discs by CFU studies. These results were confirmed by SEM studies of biofilm formation by S. salivarius, S. sanguis, or S. mutans or a mixture of all three bacteria, where the Ag-gel dressing showed total inhibition of biofilm formation on cellulose discs. These results indicate that use of a colloidal silver gel is an effective way to inhibit the formation of biofilms by the most common bacteria implicated in oral plaque formation, and this gel stands good potential to be developed into an effective commercial dentifrice product.

Data availability

Raw data for this study are available on OSF. DOI: https://doi.org/10.17605/OSF.IO/AJNYU¹⁹.

Data are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).

Grant information

This study was funded by Viridis BioPharma Pvt. Ltd.

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Faculty Opinions recommended

References

1. Lansdown AB: Silver I: Its antibacterial properties and mechanism of action. J Wound Care. 2002; 11(4): 125–30. PubMed Abstract | Publisher Full Text
2. Tredget EE, Shankowsky HA, Groeneveld A, et al.: A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil. 1998; 19(6): 531–537. PubMed Abstract | Publisher Full Text
3. Wright JB, Lam K, Burrell RE: Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. Am J Infect Control. 1998; 26(6): 572–7. PubMed Abstract | Publisher Full Text
4. Yin HQ, Langford R, Burrell RE: Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil. 1999; 20(3): 195–200. PubMed Abstract | Publisher Full Text
5. Thomas S, McCubbin P: A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care. 2003; 12(3): 101–7. PubMed Abstract | Publisher Full Text
6. Thomas S, McCubbin P: An in vitro analysis of the antimicrobial properties of 10 silver-containing dressings. J Wound Care. 2003; 12(8): 305–8. PubMed Abstract | Publisher Full Text
7. Dunn K, Edwards-Jones V: The role of Acticoat with nanocrystalline silver in the management of burns. Burns. 2004; 30 Suppl: S1–9. PubMed Abstract | Publisher Full Text
8. Da Silva NB, Alexandria AK, De Lima AL, et al.: In vitro antimicrobial activity of mouth washes and herbal products against dental biofilm-forming bacteria. Contemp Clin Dent. 2012; 3(3): 302–5. PubMed Abstract | Publisher Full Text | Free Full Text
9. Aneja KR, Joshi R, Sharma C: The antimicrobial potential of ten often used mouthwashes against four dental caries pathogens. Jundishapur J Microbiol. 2010; 3(1): 15–27. Reference Source
10. Prabu GR, Gnanamani A, Sadulla S: Guaijaverin -- a plant flavonoid as potential antiplaque agent against Streptococcus mutans. J App Microbiol. 2006; 101(2): 487–95. PubMed Abstract | Publisher Full Text
11. Fong J, Wood F: Nanocrystalline silver dressings in wound management: a review. Int J Nanomedicine. 2006; 1(4): 441–9. PubMed Abstract | Free Full Text
12. Fong J, Wood F, Fowler B: A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits. Burns. 2005; 31(5): 562–7. PubMed Abstract | Publisher Full Text
13. Kroes I, Lepp PW, Relman DA: Bacterial diversity within the human subgingival crevice. Proc Natl Acad Sci U S A. 1999; 96(25): 14547–52. PubMed Abstract | Publisher Full Text | Free Full Text
14. Paster BJ, Boches SK, Galvin JL, et al.: Bacterial diversity in human subgingival plaque. J Bacteriol. 2001; 183(12): 3770–83. PubMed Abstract | Publisher Full Text | Free Full Text
15. Aas JA, Paster BJ, Stokes LN, et al.: Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005; 43(11): 5721–32. PubMed Abstract | Publisher Full Text | Free Full Text
16. Tran PL, Hammond AA, Mosley T, et al.: Organoselenium coating on cellulose inhibits the formation of biofilms by Pseudomonas aeruginosa and Staphylococcus aureus. Appl Environ Microbiol. 2009; 75(11): 3586–92. PubMed Abstract | Publisher Full Text | Free Full Text
17. Araujo JC, Téran FC, Oliveira RA, et al.: Comparison of hexamethyldisilazane and critical point drying treatments for SEM analysis of anaerobic biofilms and granular sludge. J Electron Microsc (Tokyo). 2003; 52(4): 429–33. PubMed Abstract | Publisher Full Text
18. Braet F, De Zanger R, Wisse E: Drying cells for SEM, AFM and TEM by hexamethyldisilazane: a study on hepatic endothelial cells. J Microsc. 1997; 186(Pt 1): 84–7. PubMed Abstract | Publisher Full Text
19. Mehta D: “Efficacy of a Silver Colloidal Gel against Selected Oral Bacteria in Vitro.” OSF. 2019. http://www.doi.org/10.17605/OSF.IO/AJNYU
20. Caufield PW, Dasanayake AP, Li Y, et al.: Natural history of Streptococcus sanguinis in the oral cavity of infants: evidence for a discrete window of infectivity. Infect Immun. 2000; 68(7): 4018–23. PubMed Abstract | Publisher Full Text | Free Full Text
21. Paik S, Senty L, Das S, et al.: Identification of virulence determinants for endocarditis in Streptococcus sanguinis by signature-tagged mutagenesis. Infect Immun. 2005; 73(9): 6064–74. PubMed Abstract | Publisher Full Text | Free Full Text
22. Xu P, Alves JM, Kitten T, et al.: Genome of the opportunistic pathogen Streptococcus sanguinis. J Bacteriol. 2007; 189(8): 3166–75. PubMed Abstract | Publisher Full Text | Free Full Text
23. Hamada S, Slade HD: Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev. 1980; 44(2): 331–84. PubMed Abstract | Free Full Text
24. Loesche WJ: Role of Streptococcus mutans in human dental decay. Microbiol Rev. 1986; 50(4): 353–80. PubMed Abstract | Free Full Text
25. Da Silva AC, Cruz Jdos S, Sampaio F, et al.: Detection of oral streptococci in dental biofilm from caries-active and caries-free children. Braz J Microbiol. 2008; 39(4): 648–51. PubMed Abstract | Publisher Full Text | Free Full Text
26. Wescombe PA, Hale JD, Heng NC, et al.: Developing oral probiotics from Streptococcus salivarius. Future Microbiol. 2012; 7(12): 1355–71. PubMed Abstract | Publisher Full Text
27. Kreth J, Merritt J, Shi W, et al.: Competition and coexistence between Streptococcus mutans and Streptococcus sanguinis in the dental biofilm. J Bacteriol. 2005; 187(21): 7193–203. PubMed Abstract | Publisher Full Text | Free Full Text
28. Ogawa A, Furukawa S, Fujita S, et al.: Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA. Appl Environ Microbiol. 2011; 77(5): 1572–80. PubMed Abstract | Publisher Full Text | Free Full Text
29. Nakano K, Inaba H, Nomura R, et al.: Detection of cariogenic Streptococcus mutans in extirpated heart valve and atheromatous plaque specimens. J Clin Microbiol. 2006; 44(9): 3313–17. PubMed Abstract | Publisher Full Text | Free Full Text
30. Megarbane B, Casetta A, Esvant H, et al.: Streptococcus salivarius acute meningitis with latent petromastoiditis. Scand J Infect Dis. 2000; 32(3): 322–3. PubMed Abstract | Publisher Full Text
31. Rafailidis PI, Prapas SN, Kasiakou SK, et al.: Effusive-constrictive calcific pericarditis associated with Streptococcus salivarius. Case report and review of the literature. Cardiol Rev. 2005; 13(3): 113–7. PubMed Abstract | Publisher Full Text
32. Lee TH, Hsueh PR, Yeh WC, et al.: Low frequency of bacteremia after endoscopic mucosal resection. Gastrointest Endosc. 2000; 52(2): 223–5. PubMed Abstract | Publisher Full Text
33. Corredoira JC, Alonso MP, Garcia JF, et al.: Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study. Eur J Clin Microbiol Infect Dis. 2005; 24(4): 250–255. PubMed Abstract | Publisher Full Text
34. Conte A, Chinello P, Civljak R, et al.: Streptococcus salivarius meningitis and sphenoid sinus mucocele. Case report and literature review. J Infect. 2006; 52(1): e27–30. PubMed Abstract | Publisher Full Text
35. Yaniv LG, Potasman I: Iatrogenic meningitis: an increasing role for resistant viridans streptococci? Case report and review of the last 20 years. Scand J Infect Dis. 2000; 32(6): 693–6. PubMed Abstract | Publisher Full Text
36. Trautmann M, Lepper PM, Schmitz FJ: Three cases of bacterial meningitis after spinal and epidural anesthesia. Eur J Clin Microbiol Infect Dis. 2002; 21: 43–5. PubMed Abstract | Publisher Full Text
37. Bouhemad B, Dounas M, Mercier FJ, et al.: Bacterial meningitis following combined spinal-epidural analgesia for labour. Anaesthesia. 1998; 53: 292–5. PubMed Abstract | Publisher Full Text
38. Veringa E, Van Belkum A, Schellekens H: Iatrogenic meningitis by Streptococcus salivarius following lumbar puncture. J Hosp Infect. 1995; 29: 316–8. PubMed Abstract | Publisher Full Text
39. Wisplinghoff H, Reinert RR, Cornely O, et al.: Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. J Clin Microbiol. 1999; 37: 1876–80. PubMed Abstract | Free Full Text

Comments on this article Comments (0)

Version 1

VERSION 1 PUBLISHED 07 Mar 2019

Author details Author details

¹ Departments of Ophthalmology and Visual Sciences, Texas Tech University Health Sciences Center, Lubbock, Texas, USA
² Viridis BioPharma Pvt Ltd, Mumbai, Maharashtra, India
³ American Biotech Labs LLC, Alpine, Utah, USA
⁴ Selenium Ltd, Austin, TX, USA

Phat L. Tran
Roles: Investigation, Writing – Review & Editing

Keaton Luth
Roles: Writing – Review & Editing

James Wang
Roles: Writing – Review & Editing

Coby Ray
Roles: Writing – Review & Editing

Anselm de Souza
Roles: Conceptualization

Dilip Mehta
Roles: Conceptualization, Writing – Original Draft Preparation, Writing – Review & Editing

K. W. Moeller
Roles: Writing – Review & Editing

C. D. Moeller
Roles: Writing – Review & Editing

Ted W. Reid
Roles: Project Administration, Writing – Original Draft Preparation, Writing – Review & Editing

Competing interests

Dr. Dilip Mehta and Dr. Anselm de Souza are directors at Viridis BioPharma Pvt. Ltd. and K W Moeller and C D Moeller are directors at American Biotech Labs.

Grant information

This study was funded by Viridis BioPharma Pvt. Ltd.
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Article Versions (1)

version 1

Published: 07 Mar 2019, 8:267

https://doi.org/10.12688/f1000research.17707.1

Copyright

© 2019 Tran PL et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Download

Export To

metrics

	Views	Downloads
F1000Research	-	-
PubMed Central Data from PMC are received and updated monthly.	-	-

Citations

0

SEE MORE DETAILS

CITE

how to cite this article

Tran PL, Luth K, Wang J et al. Efficacy of a silver colloidal gel against selected oral bacteria in vitro [version 1; peer review: 2 approved, 1 approved with reservations]. F1000Research 2019, 8:267 (https://doi.org/10.12688/f1000research.17707.1)

NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.

track

receive updates on this article

Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?

Key to Reviewer Statuses VIEW HIDE

ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested

Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.

Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions

Version 1

VERSION 1

PUBLISHED 07 Mar 2019

Views

14

Reviewer Report 15 May 2019

C S Srinandan, Biofilm Biology Lab, Centre for Research on Infectious Diseases, School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, India

Approved with Reservations

https://doi.org/10.5256/f1000research.19360.r47334

This study by Tran et al., is important, but preliminary report that shows colloidal silver to be effective against three Streptococcus species. Following are some of the concerns I have regarding this manuscript.

The

This study by Tran et al., is important, but preliminary report that shows colloidal silver to be effective against three Streptococcus species. Following are some of the concerns I have regarding this manuscript.

The authors state that “the Ag-gel should be tested for the ability to block plaque formation in the mouth, through its use as a toothpaste”. Let’s consider the following: (a) Oral microbiome is very rich and its composition is important for health status of an individual and (b) Literature says colloidal silver is toxic to the host cells.

Considering (a) and (b), using the Ag-gel as a toothpaste may not be a good idea as it is not specific towards the pathogens. Thus, I recommend the authors to measure the cost-benefit ratio and mention about the conditions or stages of oral disease at which it could possibly be used as a toothpaste.

Why only one concentration of 0.5g of colloidal silver used for the studies?
Please provide the details for the figures in the legends, like (i) what is the sample size, (ii) what do the error bars indicate, and (iii) which statistical test was performed on the data.
I fail to understand the biological relevance of negative data of CFU in Fig. 1.
What happens to biofilm formation at lower concentrations of silver?
As the previous reviewers commented, eradication of biofilms should also be tested. Therefore, this manuscript should accompany the Minimum Biofilm Inhibitory Concentration (MBIC) and Minimum Biofilm Eradication Concentration (MBEC) of colloidal silver.
Determination of interaction of colloidal silver with antibiotics is also an important test that has to be performed.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

No
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Partly
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

No

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Biofilms.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

CITE

Report a concern

Respond or Comment

Views

13

Reviewer Report 16 Apr 2019

Mohan Kulkarni, Department of Chemistry, Biochemistry Division, Savitribai Phule Pune University, Pune, India

Approved

https://doi.org/10.5256/f1000research.19360.r45453

Caries has been the one of the most prevalent dental conditions which needs effective treatment. Products currently in use such as mouthwashes recommended for oral hygiene are not very effective against dental biofilm formation.

This study evaluates ... Continue reading

Caries has been the one of the most prevalent dental conditions which needs effective treatment. Products currently in use such as mouthwashes recommended for oral hygiene are not very effective against dental biofilm formation.

This study evaluates the efficacy of colloidal silver gel formulations in inhibiting bacterial biofilm formation by S. mutans, S. sanguis, and S. salivarius which cause plaque formation. The choice of colloidal silver over ionic silver in view of its lower toxicity is well justified and so also the choice of bacteria for evaluating the efficacy of colloidal silver.

The effectiveness of colloidal silver has been demonstrated by quantifying colony forming units (CFU). Appropriate controls and statistical analyses have been provided to support the results. The results are further supported by scanning electron microscopy. The results show that no biofilms are formed in the presence of colloidal silver gel but do form in the control experiments carried out with placebo.

Since the objective of the work is to develop a treatment for the prevention of caries, it would be desirable to optimize the concentration of colloidal silver in the gel in future. In addition to prevention of biofilm formation if colloidal silver is shown to be useful in disrupting biofilms already formed, it would enhance the scope of treatment.

I recommend the indexing of the paper “Efficacy of a silver colloidal gel against selected oral bacteria in vitro”.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Yes

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Polymers, nanoparticles, drug delivery, patents.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

CITE

Report a concern

Respond or Comment

Views

37

Reviewer Report 11 Mar 2019

Vijay Kothari, Institute of Science, Nirma University, Ahmedabad, India

Approved

https://doi.org/10.5256/f1000research.19360.r45449

This study has evaluated antibacterial efficacy of a colloidal silver gel against three important oral bacteria. In context of the currently available dentifrice products not being full effective in preventing the widespread problem of dental caries, need and research for ... Continue reading

This study has evaluated antibacterial efficacy of a colloidal silver gel against three important oral bacteria. In context of the currently available dentifrice products not being full effective in preventing the widespread problem of dental caries, need and research for new more effective dentifrices is justified. Their idea of assaying the test gel not only against individual bacteria, but also against the mixed-species is a logical one, as that represents real-life situations a bit more closely. In the recent past, maintenance of good oral health has been shown to be important for good cardiovascular health, healthy pregnancy, etc.

They may consider re-framing the last sentence of the third paragraph in 'Introduction'. They may also check for correct placement of all references; For e.g. references 2-3 have been cited in first paragraph in an oral health context, but their titles seem to be more relevant to wound management.

While, I do not have any reservations in recommending this article in its present form for indexing, I suggest for following additional experiments for future studies by these authors:

Effect of this gel on pre-formed biofilms of oral bacteria should be checked on two different parameters i.e. whether this gel can kill bacteria in biofilm, and whether it can eradicate the pre-formed biofilm with/without killing the bacteria in it.
Results of current study indicate their gel to possess a bactericidal action. They may consider extending the incubation till 48-72 hours after transferring the gel-exposed bacteria onto fresh gel-free media, to confirm the true bactericidal effect, and absence of post-antibiotic effect (PAE).
They may consider determination of MIC, MBC, and time required to kill. The latter is important as typical dentifrice products like mouthwashes/toothpaste get few seconds/minutes to exert their effect in the mouth.
It will be interesting to investigate whether at sub-inhibitory concentrations their product can reduce lactic acid production by the Streptococci, which is a major virulence factor involved in demineralization of teeth. Whether sub-inhibitory concentrations can inhibit quorum-sensing in these bacteria?
In the current study, cellulose discs were used as surface for biofilm formation. In future studies, they may consider some material similar to teeth-substance (e.g. calcium) as the surface for biofilm formation.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Yes

Competing Interests: No competing interests were disclosed.

Reviewer Expertise: Antimicrobial Resistance (AMR); Bacterial biofilms; Antimicrobials; Traditional Medicine; Bioacoustics; Plant extracts; Quorum Sensing

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

CITE

Report a concern

Respond or Comment

Comments on this article Comments (0)

Version 1

VERSION 1 PUBLISHED 07 Mar 2019

Open Peer Review

Reviewer Status

Reviewer Reports

	Invited Reviewers
	1	2	3
Version 1 07 Mar 19	read	read	read

Vijay Kothari, Nirma University, Ahmedabad, India
Mohan Kulkarni, Savitribai Phule Pune University, Pune, India
C S Srinandan, SASTRA Deemed University, Thanjavur, India

Comments on this article

All Comments(0)

Add a comment

Sign up for content alerts

Browse by related subjects

Back to all reports

Reviewer Report

14 Views

15 May 2019 | for Version 1

C S Srinandan, Biofilm Biology Lab, Centre for Research on Infectious Diseases, School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, India

14 Views Cite this report Responses(0)

Approved With Reservations

This study by Tran et al., is important, but preliminary report that shows colloidal silver to be effective against three Streptococcus species. Following are some of the concerns I have regarding this manuscript.

The authors state that “the Ag-gel should be tested for the ability to block plaque formation in the mouth, through its use as a toothpaste”. Let’s consider the following: (a) Oral microbiome is very rich and its composition is important for health status of an individual and (b) Literature says colloidal silver is toxic to the host cells.

Considering (a) and (b), using the Ag-gel as a toothpaste may not be a good idea as it is not specific towards the pathogens. Thus, I recommend the authors to measure the cost-benefit ratio and mention about the conditions or stages of oral disease at which it could possibly be used as a toothpaste.

Why only one concentration of 0.5g of colloidal silver used for the studies?
Please provide the details for the figures in the legends, like (i) what is the sample size, (ii) what do the error bars indicate, and (iii) which statistical test was performed on the data.
I fail to understand the biological relevance of negative data of CFU in Fig. 1.
What happens to biofilm formation at lower concentrations of silver?
As the previous reviewers commented, eradication of biofilms should also be tested. Therefore, this manuscript should accompany the Minimum Biofilm Inhibitory Concentration (MBIC) and Minimum Biofilm Eradication Concentration (MBEC) of colloidal silver.
Determination of interaction of colloidal silver with antibiotics is also an important test that has to be performed.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

No
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Partly
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

No

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Biofilms.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

13 Views

16 Apr 2019 | for Version 1

Mohan Kulkarni, Department of Chemistry, Biochemistry Division, Savitribai Phule Pune University, Pune, India

13 Views Cite this report Responses(0)

Approved

Caries has been the one of the most prevalent dental conditions which needs effective treatment. Products currently in use such as mouthwashes recommended for oral hygiene are not very effective against dental biofilm formation.

This study evaluates the efficacy of colloidal silver gel formulations in inhibiting bacterial biofilm formation by S. mutans, S. sanguis, and S. salivarius which cause plaque formation. The choice of colloidal silver over ionic silver in view of its lower toxicity is well justified and so also the choice of bacteria for evaluating the efficacy of colloidal silver.

The effectiveness of colloidal silver has been demonstrated by quantifying colony forming units (CFU). Appropriate controls and statistical analyses have been provided to support the results. The results are further supported by scanning electron microscopy. The results show that no biofilms are formed in the presence of colloidal silver gel but do form in the control experiments carried out with placebo.

Since the objective of the work is to develop a treatment for the prevention of caries, it would be desirable to optimize the concentration of colloidal silver in the gel in future. In addition to prevention of biofilm formation if colloidal silver is shown to be useful in disrupting biofilms already formed, it would enhance the scope of treatment.

I recommend the indexing of the paper “Efficacy of a silver colloidal gel against selected oral bacteria in vitro”.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Yes

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Polymers, nanoparticles, drug delivery, patents.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Respond to this report

Responses (0)

Back to all reports

Reviewer Report

37 Views

11 Mar 2019 | for Version 1

Vijay Kothari, Institute of Science, Nirma University, Ahmedabad, India

37 Views Cite this report Responses(0)

Approved

This study has evaluated antibacterial efficacy of a colloidal silver gel against three important oral bacteria. In context of the currently available dentifrice products not being full effective in preventing the widespread problem of dental caries, need and research for new more effective dentifrices is justified. Their idea of assaying the test gel not only against individual bacteria, but also against the mixed-species is a logical one, as that represents real-life situations a bit more closely. In the recent past, maintenance of good oral health has been shown to be important for good cardiovascular health, healthy pregnancy, etc.

They may consider re-framing the last sentence of the third paragraph in 'Introduction'. They may also check for correct placement of all references; For e.g. references 2-3 have been cited in first paragraph in an oral health context, but their titles seem to be more relevant to wound management.

While, I do not have any reservations in recommending this article in its present form for indexing, I suggest for following additional experiments for future studies by these authors:

Effect of this gel on pre-formed biofilms of oral bacteria should be checked on two different parameters i.e. whether this gel can kill bacteria in biofilm, and whether it can eradicate the pre-formed biofilm with/without killing the bacteria in it.
Results of current study indicate their gel to possess a bactericidal action. They may consider extending the incubation till 48-72 hours after transferring the gel-exposed bacteria onto fresh gel-free media, to confirm the true bactericidal effect, and absence of post-antibiotic effect (PAE).
They may consider determination of MIC, MBC, and time required to kill. The latter is important as typical dentifrice products like mouthwashes/toothpaste get few seconds/minutes to exert their effect in the mouth.
It will be interesting to investigate whether at sub-inhibitory concentrations their product can reduce lactic acid production by the Streptococci, which is a major virulence factor involved in demineralization of teeth. Whether sub-inhibitory concentrations can inhibit quorum-sensing in these bacteria?
In the current study, cellulose discs were used as surface for biofilm formation. In future studies, they may consider some material similar to teeth-substance (e.g. calcium) as the surface for biofilm formation.

Is the work clearly and accurately presented and does it cite the current literature?

Yes
Is the study design appropriate and is the work technically sound?

Yes
Are sufficient details of methods and analysis provided to allow replication by others?

Yes
If applicable, is the statistical analysis and its interpretation appropriate?

Yes
Are all the source data underlying the results available to ensure full reproducibility?

Yes
Are the conclusions drawn adequately supported by the results?

Yes

Competing Interests

No competing interests were disclosed.

Reviewer Expertise

Antimicrobial Resistance (AMR); Bacterial biofilms; Antimicrobials; Traditional Medicine; Bioacoustics; Plant extracts; Quorum Sensing

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Respond to this report

Responses (0)

[1] 1. Lansdown AB: Silver I: Its antibacterial properties and mechanism of action. J Wound Care. 2002; 11(4): 125–30. PubMed Abstract | Publisher Full Text

[2] 2. Tredget EE, Shankowsky HA, Groeneveld A, et al.: A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds. J Burn Care Rehabil. 1998; 19(6): 531–537. PubMed Abstract | Publisher Full Text

[3] 3. Wright JB, Lam K, Burrell RE: Wound management in an era of increasing bacterial antibiotic resistance: a role for topical silver treatment. Am J Infect Control. 1998; 26(6): 572–7. PubMed Abstract | Publisher Full Text

[4] 4. Yin HQ, Langford R, Burrell RE: Comparative evaluation of the antimicrobial activity of ACTICOAT antimicrobial barrier dressing. J Burn Care Rehabil. 1999; 20(3): 195–200. PubMed Abstract | Publisher Full Text

[5] 5. Thomas S, McCubbin P: A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care. 2003; 12(3): 101–7. PubMed Abstract | Publisher Full Text

[6] 6. Thomas S, McCubbin P: An in vitro analysis of the antimicrobial properties of 10 silver-containing dressings. J Wound Care. 2003; 12(8): 305–8. PubMed Abstract | Publisher Full Text

[7] 7. Dunn K, Edwards-Jones V: The role of Acticoat with nanocrystalline silver in the management of burns. Burns. 2004; 30 Suppl: S1–9. PubMed Abstract | Publisher Full Text

[8] 8. Da Silva NB, Alexandria AK, De Lima AL, et al.: In vitro antimicrobial activity of mouth washes and herbal products against dental biofilm-forming bacteria. Contemp Clin Dent. 2012; 3(3): 302–5. PubMed Abstract | Publisher Full Text | Free Full Text

[9] 9. Aneja KR, Joshi R, Sharma C: The antimicrobial potential of ten often used mouthwashes against four dental caries pathogens. Jundishapur J Microbiol. 2010; 3(1): 15–27. Reference Source

[10] 10. Prabu GR, Gnanamani A, Sadulla S: Guaijaverin -- a plant flavonoid as potential antiplaque agent against Streptococcus mutans. J App Microbiol. 2006; 101(2): 487–95. PubMed Abstract | Publisher Full Text

[11] 11. Fong J, Wood F: Nanocrystalline silver dressings in wound management: a review. Int J Nanomedicine. 2006; 1(4): 441–9. PubMed Abstract | Free Full Text

[12] 12. Fong J, Wood F, Fowler B: A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits. Burns. 2005; 31(5): 562–7. PubMed Abstract | Publisher Full Text

[13] 13. Kroes I, Lepp PW, Relman DA: Bacterial diversity within the human subgingival crevice. Proc Natl Acad Sci U S A. 1999; 96(25): 14547–52. PubMed Abstract | Publisher Full Text | Free Full Text

[14] 14. Paster BJ, Boches SK, Galvin JL, et al.: Bacterial diversity in human subgingival plaque. J Bacteriol. 2001; 183(12): 3770–83. PubMed Abstract | Publisher Full Text | Free Full Text

[15] 15. Aas JA, Paster BJ, Stokes LN, et al.: Defining the normal bacterial flora of the oral cavity. J Clin Microbiol. 2005; 43(11): 5721–32. PubMed Abstract | Publisher Full Text | Free Full Text

[16] 16. Tran PL, Hammond AA, Mosley T, et al.: Organoselenium coating on cellulose inhibits the formation of biofilms by Pseudomonas aeruginosa and Staphylococcus aureus. Appl Environ Microbiol. 2009; 75(11): 3586–92. PubMed Abstract | Publisher Full Text | Free Full Text

[17] 17. Araujo JC, Téran FC, Oliveira RA, et al.: Comparison of hexamethyldisilazane and critical point drying treatments for SEM analysis of anaerobic biofilms and granular sludge. J Electron Microsc (Tokyo). 2003; 52(4): 429–33. PubMed Abstract | Publisher Full Text

[18] 18. Braet F, De Zanger R, Wisse E: Drying cells for SEM, AFM and TEM by hexamethyldisilazane: a study on hepatic endothelial cells. J Microsc. 1997; 186(Pt 1): 84–7. PubMed Abstract | Publisher Full Text

[19] 19. Mehta D: “Efficacy of a Silver Colloidal Gel against Selected Oral Bacteria in Vitro.” OSF. 2019. http://www.doi.org/10.17605/OSF.IO/AJNYU

[20] 20. Caufield PW, Dasanayake AP, Li Y, et al.: Natural history of Streptococcus sanguinis in the oral cavity of infants: evidence for a discrete window of infectivity. Infect Immun. 2000; 68(7): 4018–23. PubMed Abstract | Publisher Full Text | Free Full Text

[21] 21. Paik S, Senty L, Das S, et al.: Identification of virulence determinants for endocarditis in Streptococcus sanguinis by signature-tagged mutagenesis. Infect Immun. 2005; 73(9): 6064–74. PubMed Abstract | Publisher Full Text | Free Full Text

[22] 22. Xu P, Alves JM, Kitten T, et al.: Genome of the opportunistic pathogen Streptococcus sanguinis. J Bacteriol. 2007; 189(8): 3166–75. PubMed Abstract | Publisher Full Text | Free Full Text

[23] 23. Hamada S, Slade HD: Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev. 1980; 44(2): 331–84. PubMed Abstract | Free Full Text

[24] 24. Loesche WJ: Role of Streptococcus mutans in human dental decay. Microbiol Rev. 1986; 50(4): 353–80. PubMed Abstract | Free Full Text

[25] 25. Da Silva AC, Cruz Jdos S, Sampaio F, et al.: Detection of oral streptococci in dental biofilm from caries-active and caries-free children. Braz J Microbiol. 2008; 39(4): 648–51. PubMed Abstract | Publisher Full Text | Free Full Text

[26] 26. Wescombe PA, Hale JD, Heng NC, et al.: Developing oral probiotics from Streptococcus salivarius. Future Microbiol. 2012; 7(12): 1355–71. PubMed Abstract | Publisher Full Text

[27] 27. Kreth J, Merritt J, Shi W, et al.: Competition and coexistence between Streptococcus mutans and Streptococcus sanguinis in the dental biofilm. J Bacteriol. 2005; 187(21): 7193–203. PubMed Abstract | Publisher Full Text | Free Full Text

[28] 28. Ogawa A, Furukawa S, Fujita S, et al.: Inhibition of Streptococcus mutans biofilm formation by Streptococcus salivarius FruA. Appl Environ Microbiol. 2011; 77(5): 1572–80. PubMed Abstract | Publisher Full Text | Free Full Text

[29] 29. Nakano K, Inaba H, Nomura R, et al.: Detection of cariogenic Streptococcus mutans in extirpated heart valve and atheromatous plaque specimens. J Clin Microbiol. 2006; 44(9): 3313–17. PubMed Abstract | Publisher Full Text | Free Full Text

[30] 30. Megarbane B, Casetta A, Esvant H, et al.: Streptococcus salivarius acute meningitis with latent petromastoiditis. Scand J Infect Dis. 2000; 32(3): 322–3. PubMed Abstract | Publisher Full Text

[31] 31. Rafailidis PI, Prapas SN, Kasiakou SK, et al.: Effusive-constrictive calcific pericarditis associated with Streptococcus salivarius. Case report and review of the literature. Cardiol Rev. 2005; 13(3): 113–7. PubMed Abstract | Publisher Full Text

[32] 32. Lee TH, Hsueh PR, Yeh WC, et al.: Low frequency of bacteremia after endoscopic mucosal resection. Gastrointest Endosc. 2000; 52(2): 223–5. PubMed Abstract | Publisher Full Text

[33] 33. Corredoira JC, Alonso MP, Garcia JF, et al.: Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study. Eur J Clin Microbiol Infect Dis. 2005; 24(4): 250–255. PubMed Abstract | Publisher Full Text

[34] 34. Conte A, Chinello P, Civljak R, et al.: Streptococcus salivarius meningitis and sphenoid sinus mucocele. Case report and literature review. J Infect. 2006; 52(1): e27–30. PubMed Abstract | Publisher Full Text

[35] 35. Yaniv LG, Potasman I: Iatrogenic meningitis: an increasing role for resistant viridans streptococci? Case report and review of the last 20 years. Scand J Infect Dis. 2000; 32(6): 693–6. PubMed Abstract | Publisher Full Text

[36] 36. Trautmann M, Lepper PM, Schmitz FJ: Three cases of bacterial meningitis after spinal and epidural anesthesia. Eur J Clin Microbiol Infect Dis. 2002; 21: 43–5. PubMed Abstract | Publisher Full Text

[37] 37. Bouhemad B, Dounas M, Mercier FJ, et al.: Bacterial meningitis following combined spinal-epidural analgesia for labour. Anaesthesia. 1998; 53: 292–5. PubMed Abstract | Publisher Full Text

[38] 38. Veringa E, Van Belkum A, Schellekens H: Iatrogenic meningitis by Streptococcus salivarius following lumbar puncture. J Hosp Infect. 1995; 29: 316–8. PubMed Abstract | Publisher Full Text

[39] 39. Wisplinghoff H, Reinert RR, Cornely O, et al.: Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients. J Clin Microbiol. 1999; 37: 1876–80. PubMed Abstract | Free Full Text

Efficacy of a silver colloidal gel against selected oral bacteria in vitro

Abstract

Keywords

Introduction

Methods

Bacterial strains, media, and growth conditions

Colloidal silver materials

In vitro colony forming unit (CFU) assays

Scanning electron microscopy (SEM)

Statistical analysis

Results

Effect of Ag-gel on bacterial biofilm formation for in vitro CFU studies

Figure 1. Colony forming unit analysis of biofilm formation.

Effect of Ag-gel dressing on bacterial biofilm formation for in vitro SEM studies

Figure 2. Scanning electron microscopy (SEM) imaging.

Discussion

Conclusion

Data availability

Grant information

References

Comments on this article Comments (0)

Open Peer Review

Comments on this article Comments (0)

Open Peer Review

Reviewer Status

Reviewer Reports

Comments on this article

Browse by related subjects

Competing Interests Policy

Stay Updated